Skip to main content
/health

Probe widens on Vytorin safety

  • Story Highlights
  • U.S. committee wants Merck, Schering-Plough to answer questions
  • Committee's letter says it got only a five-page report
  • Questions relate to safety of cholesterol drug Vytorin
  • One clinical study indicated the drug has a possible risk
  • Next Article in Health »
  • E-mail
  • Save
  • Print
Quick Job Search
keyword(s):
enter city:
Home  |  World  |  U.S.  |  Politics  |  Crime  |  Entertainment  |  Health  |  Tech  |  Travel  |  Living  |  Business  |  Sports  |  Time.com
© 2008 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.